Bioequivalence of liquid and reconstituted lyophilized etanercept subcutaneous injections

Journal of Clinical Pharmacology

Volumn 46, Issue 6, 2006, Pages 654-661

  Sullivan, John T ^a   Ni, Liyun ^a   Sheelo, Claudia ^a   Salfi, Margaret ^a   Peloso, Paul M ^a  

^a AMGEN INC   (United States)

Author keywords

Arthritis, rheumatoid; Bioequivalence; Etanercept; Pharmacokinetics; Receptors, tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ETANERCEPT; LACTATE DEHYDROGENASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE DRYING; HEADACHE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE REACTION; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINUS CONGESTION; SORE THROAT; VARIANCE;

ADULT; ANTIRHEUMATIC AGENTS; CROSS-OVER STUDIES; FEMALE; FREEZE DRYING; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; THERAPEUTIC EQUIVALENCY;

EID: 33745232468     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270006287705     Document Type: Article

References (5)

1. Korth-Bradley JM, Rubin AS, Hanna RK, Simcoe DK, Lebsack ME. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother. 2000;34:161-164.
2. Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC. Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther. 2003;73:348-365.
3. Zhou H, Buckwalter M, Boni J, et al. Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis. Int J Clin Pharm Ther. 2004;42:267-276.
4. Etanercept [prescribing information]. Thousand Oaks, Calif: Immunex Corp; 2006. Available at: http://www.enbrel.com/prescribing-information.jsp. Accessed January 24, 2006.
5. Keystone EC, Schiff MH, Kremer JM, et al. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis. Arthritis Rheum. 2004;50:353-363.